Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Champions Oncology (CSBR) Income from Continuing Operations (2016 - 2026)

Champions Oncology has reported Income from Continuing Operations over the past 17 years, most recently at 279000.0 for Q1 2026.

  • Quarterly results put Income from Continuing Operations at 279000.0 for Q1 2026, down 106.21% from a year ago — trailing twelve months through Jan 2026 was 2343000.0 (down 136.46% YoY), and the annual figure for FY2025 was 4701000.0, up 164.61%.
  • Income from Continuing Operations for Q1 2026 was 279000.0 at Champions Oncology, down from 237000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for CSBR hit a ceiling of 4495000.0 in Q1 2025 and a floor of 2566000.0 in Q3 2023.
  • Median Income from Continuing Operations over the past 5 years was 319000.0 (2022), compared with a mean of 469117.65.
  • Biggest five-year swings in Income from Continuing Operations: tumbled 12843.75% in 2023 and later soared 277.67% in 2025.
  • Champions Oncology's Income from Continuing Operations stood at 16000.0 in 2022, then tumbled by 12843.75% to 2071000.0 in 2023, then skyrocketed by 135.15% to 728000.0 in 2024, then plummeted by 67.45% to 237000.0 in 2025, then crashed by 217.72% to 279000.0 in 2026.
  • The last three reported values for Income from Continuing Operations were 279000.0 (Q1 2026), 237000.0 (Q4 2025), and 466000.0 (Q3 2025) per Business Quant data.